OCA real world experience
Since OCA (Ocaliva) was approved in the US in 2016 and Canada in 2017, there have been several studies to assess its effectiveness in PBC patients around the world. Here are some links to those studies.
Hirschfield, Hansen: OCA improves AST-to-platelet ratio index and GLOBE score in PBC
Italian real-world experience with OCA
Iberian real-world experience with OCA
Canadian (CaNAL) real-world experience with OCA (July 2020)